High expression of disease-related Cln6 in the cerebral cortex, Purkinje cells, dentate gyrus, and hippocampal ca1 neurons

Journal of Neuroscience Research

Volumn 90, Issue 3, 2012, Pages 568-574

  Thelen, Melanie ^a   Fehr, Susanne ^a   Schweizer, Michaela ^a   Braulke, Thomas ^a   Galliciotti, Giovanna ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Hippocampus; In situ hybridization; Lysosomal storage disorder; nclf; Neuronal ceroid lipofuscinosis

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN CLN6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPAL CA1 REGION; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MOUSE; NERVE DEGENERATION; NEURONAL CEROID LIPOFUSCINOSIS; NEWBORN; NONHUMAN; NORTHERN BLOTTING; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

AGE FACTORS; ANIMALS; CA1 REGION, HIPPOCAMPAL; CEREBRAL CORTEX; DENTATE GYRUS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEURONS; ORGAN SPECIFICITY; PURKINJE CELLS; RNA, MESSENGER;

EID: 84855870087     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22773     Document Type: Article

References (37)

1. Arsov T, Smith KR, Damiano J, Franceschetti S, Canafoglia L, Bromhead CJ, Andermann E, Vears DF, Cossette P, Rajagopalan S, McDougall A, Sofia V, Farrell M, Aguglia U, Zini A, Meletti S, Morbin M, Mullen S, Andermann F, Mole SE, Bahlo M, Berkovic SF. 2011. Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet 88: 566-573.
2. Benedict JW, Getty AL, Wishart TM, Gillingwater TH, Pearce DA. 2009. Protein product of CLN6 gene responsible for variant late-onset infantile neuronal ceroid lipofuscinosis interacts with CRMP-2. J Neurosci Res 87: 2157-2166.
3. Bronson RT, Donahue LR, Johnson KR, Tanner A, Lane PW, Faust JR. 1998. Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9. Am J Med Genet 77: 289-297.
4. Cao Y, Staropoli JF, Biswas S, Espinola JA, Macdonald ME, Lee JM, Cotman SL. 2011. Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells. PLoS One 6: e17118.
5. Cooper JD. 2003. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Curr Opin Neurol 16: 121-128.
6. Cooper JD, Russell C, Mitchison HM. 2006. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 1762: 873-889.
7. Cotman SL, Vrbanac V, Lebel LA, Lee RL, Johnson KA, Donahue LR, Teed AM, Antonellis K, Bronson RT, Lerner TJ, MacDonald ME. 2002. Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum Mol Genet 11: 2709-2721.
8. Eliason SL, Stein CS, Mao Q, Tecedor L, Ding SL, Gaines DM, Davidson BL. 2007. A knock-in reporter model of Batten disease. J Neurosci 27: 9826-9834.
9. Elleder M, Sokolova J, Hrebicek M. 1997. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol 93: 379-390.
10. Gao H, Boustany RM, Espinola JA, Cotman SL, Srinidhi L, Antonellis KA, Gillis T, Qin X, Liu S, Donahue LR, Bronson RT, Faust JR, Stout D, Haines JL, Lerner TJ, MacDonald ME. 2002. Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet 70: 324-335.
11. Goebel HH, Wisniewski KE. 2004. Current state of clinical and morphological features in human NCL. Brain Pathol 14: 61-69.
12. Heine C, Koch B, Storch S, Kohlschütter A, Palmer DN, Braulke T. 2004. Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A. J Biol Chem 279: 22347-22352.
13. Heine C, Quitsch A, Storch S, Martin Y, Lonka L, Lehesjoki AE, Mole SE, Braulke T. 2007. Topology and endoplasmic reticulum retention signals of the lysosomal storage disease-related membrane protein CLN6. Mol Membrane Biol 24: 74-87.
14. Holmberg V, Jalanko A, Isosomppi J, Fabritius AL, Peltonen L, Kopra O. 2004. The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain. Neurobiol Dis 16: 29-40.
15. Isosomppi J, Heinonen O, Hiltunen JO, Greene ND, Vesa J, Uusitalo A, Mitchison HM, Saarma M, Jalanko A, Peltonen L. 1999. Developmental expression of palmitoyl protein thioesterase in normal mice. Brain Res Dev Brain Res 118: 1-11.
16. Jabs S, Quitsch A, Käkelä R, Koch B, Tyynelä J, Brade H, Glatzel M, Walkley S, Saftig P, Vanier MT, Braulke T. 2008. Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis. J Neurochem 106: 1415-1425.
17. Jalanko A, Braulke T. 2009. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 1793: 697-709.
18. Jolly RD, Martinus RD, Palmer DN. 1992. Sheep and other animals with ceroid-lipofuscinoses: their relevance to Batten disease. Am J Med Genet 42: 609-614.
19. Kopra O, Vesa J, von Schantz C, Manninen T, Minye H, Fabritius AL, Rapola J, van Diggelen OP, Saarela J, Jalanko A, Peltonen L. 2004. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Hum Mol Genet 13: 2893-2906.
20. Kurze AK, Galliciotti G, Heine C, Mole SE, Quitsch A, Braulke T. 2010. Pathogenic mutations cause rapid degradation of lysosomal storage disease-related membrane protein CLN6. Hum Mutat 31: E1163-E1174.
21. -Delta Delta Ct method. Methods 25: 402-408.
22. Lonka L, Aalto A, Kopra O, Kuronen M, Kokaia Z, Saarma M, Lehesjoki AE. 2005. The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy. BMC Neurosci 6: 27.
23. Lyly A, von Schantz C, Heine C, Schmiedt ML, Sipila T, Jalanko A, Kyttälä A. 2009. Novel interactions of CLN5 support molecular networking between neuronal ceroid lipofuscinosis proteins. BMC Cell Biol 10: 83.
24. Lynch MA. 2004. Long-term potentiation and memory. Physiol Rev 84: 87-136.
25. Mole SE, Michaux G, Codlin S, Wheeler RB, Sharp JD, Cutler DF. 2004. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Exp Cell Res 298: 399-406.
26. Mole SE, Williams RE, Goebel HH. 2005. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6: 107-126.
27. Oswald MJ, Palmer DN, Kay GW, Shemilt SJ, Rezaie P, Cooper JD. 2005. Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6). Neurobiol Dis 20: 49-63.
28. Oswald MJ, Palmer DN, Kay GW, Barwell KJ, Cooper JD. 2008. Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis. Neurobiol Dis 32: 50-65.
29. Palmer DN, Barns G, Husbands DR, Jolly RD. 1986. Ceroid lipofuscinosis in sheep. II. The major component of the lipopigment in liver, kidney, pancreas, and brain is low molecular weight protein. J Biol Chem 261: 1773-1777.
30. Palmer DN, Martinus RD, Cooper SM, Midwinter GG, Reid JC, Jolly RD. 1989. Ovine ceroid lipofuscinosis. The major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH2-terminal sequence. J Biol Chem 264: 5736-5740.
31. Pohl S, Mitchison HM, Kohlschütter A, van Diggelen O, Braulke T, Storch S. 2007. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue. J Neurochem 103: 2177-2188.
32. Pressey SNR, O'Donnell KJ, Stauber T, Fuhrmann JC, Tynnelä J, Jentsch TJ, Cooper JD. 2010. Distinct neuropathologic phenotypes after disrupting the chloride transport proteins ClC-6 or ClC-7/Ostm1. J Neuropathol Exp Neurol 69: 1228-1246.
33. Ranta S, Zhang Y, Ross B, Lonka L, Takkunen E, Messer A, Sharp J, Wheeler R, Kusumi K, Mole S, Liu W, Soares MB, Bonaldo MF, Hirvasniemi A, de la Chapelle A, Gilliam TC, Lehesjoki AE. 1999. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 23: 233-236.
34. Santavuori P, Vanhanen SL, Autti T. 2001. Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. Eur J Paediatr Neurol 5( Suppl A): 157-161.
35. Tammen I, Houweling PJ, Frugier T, Mitchell NL, Kay GW, Cavanagh JA, Cook RW, Raadsma HW, Palmer DN. 2006. A missense mutation (c. 184C > T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA. Biochim Biophys Acta 1762: 898-905.
36. Tyynelä J, Palmer DN, Baumann M, Haltia M. 1993. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Lett 330: 8-12.
37. Wheeler RB, Sharp JD, Schultz RA, Joslin JM, Williams RE, Mole SE. 2002. The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. Am J Hum Genet 70:537-542.